Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (231-240 of 290) with videos related to

Pageof 29
Sort By:
The European Respiratory Journal|July 11, 2015
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbationsNicole Sonneveld, Sanja Stanojevic, Reshma Amin, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern EuropeMuhammad-Hariri Mustafa, Hussein Chalhoub, Olivier Denis, et al.
The European Respiratory Journal|April 23, 2021
Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysisRebecca H McLeese, Arietta Spinou, Zina Alfahl, et al.
Thorax|April 23, 2021
Transepithelial nasal potential difference in patients with, and at risk of acute respiratory distress syndromeRob Mac Sweeney, Kiran Reddy, Jane C Davies, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samplesDominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
The New England Journal of Medicine|November 4, 2017
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delJennifer L Taylor-Cousar, Anne Munck, Edward F McKone, et al.
Journal of Healthcare Leadership|July 7, 2023
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation ScienceJames F Donohue, J Stuart Elborn, Peter Lansberg, et al.
Thorax|November 5, 2017
Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPDAlison J Dicker, Megan L Crichton, Andrew J Cassidy, et al.
ERJ Open Research|December 10, 2024
Automated method of bronchus and artery dimension measurement in an adult bronchiectasis populationAngelina L P Pieters, Qianting Lv, Jennifer J Meerburg, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
The CFTR potentiator Icenticaftor for treatment of bronchiectasis: An international phase 2, double-blind, randomized placebo-controlled trialWei-Jie Guan, Charles S Haworth, Harm A W M Tiddens, et al.
Pageof 29

Showing results (231-240 of 290) with videos related to

Sort By:
Pageof 29
The European Respiratory Journal|July 11, 2015
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbationsNicole Sonneveld, Sanja Stanojevic, Reshma Amin, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern EuropeMuhammad-Hariri Mustafa, Hussein Chalhoub, Olivier Denis, et al.
The European Respiratory Journal|April 23, 2021
Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysisRebecca H McLeese, Arietta Spinou, Zina Alfahl, et al.
Thorax|April 23, 2021
Transepithelial nasal potential difference in patients with, and at risk of acute respiratory distress syndromeRob Mac Sweeney, Kiran Reddy, Jane C Davies, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samplesDominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
The New England Journal of Medicine|November 4, 2017
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delJennifer L Taylor-Cousar, Anne Munck, Edward F McKone, et al.
Journal of Healthcare Leadership|July 7, 2023
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation ScienceJames F Donohue, J Stuart Elborn, Peter Lansberg, et al.
Thorax|November 5, 2017
Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPDAlison J Dicker, Megan L Crichton, Andrew J Cassidy, et al.
ERJ Open Research|December 10, 2024
Automated method of bronchus and artery dimension measurement in an adult bronchiectasis populationAngelina L P Pieters, Qianting Lv, Jennifer J Meerburg, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
The CFTR potentiator Icenticaftor for treatment of bronchiectasis: An international phase 2, double-blind, randomized placebo-controlled trialWei-Jie Guan, Charles S Haworth, Harm A W M Tiddens, et al.
Pageof 29